BINI and ENCO have been shown to promote epidermal growth factor receptor (EGFR)-mediated cell proliferation by deactivating the MAPK pathway and tumor growth is inhibited by the co-administration of CET [8]. The gene discussed is EGFR; the disease is neoplasm.